Interestingly, in a recent study, the Akt1 isoform was unable to induce PDGF-dependent high-grade glioma in a genetically engineered tumor model, whereas Akt2 and Akt3 isoforms strongly promoted high-grade glioma progression [8]. This evidence concerns the gene AKT2 and central nervous system cancer.